Carisma Therapeutics Inc

NASDAQ:CARM

0.22

-0.01 (-5.70%)

7:59:59 PM EDT: $0.47 +0.26 (+119.81%)

Carisma Therapeutics Inc Stock, NASDAQ:CARM

3675 Market Street, Suite 200, Philadelphia, Pennsylvania 19104

United States of America

Phone: +1.617.444.8550

Number of Employees: 107

http://carismatx.com

Description

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.